Berlin keynote details Eos SENOLYTIX's pre-clinical results with mitochondrial-targeted geropeptide on healthspan and lifespan.

As its CEO takes the stage in Berlin, the company opens a window on its longest-lived treated mice – and the data behind them ...

Avaí Bio and Austrianova began work with Ospedale San Raffaele on protecting lab-grown insulin cells from the immune system.

As pharma shops for de-risked science, venture money is moving later and concentrating in fewer, bigger bets – our report ...

Insilico Medicine nominates ISM9546, an oral VAV1 degrader designed with generative AI, as a preclinical candidate for ...

Rona Therapeutics grants Roche worldwide rights to an ALK7-silencing candidate, with up to $1.06b in further milestones on ...

KAUST and Oxford researchers used a transistor-based sensor to read three forms of alpha-synuclein, reaching 90.9% accuracy ...

Nature Biotechnology paper offers a better way to judge models that predict gene effects. Shift plans to use it to hunt for ...

German biotech MODAG won for pairing a CE-marked diagnostic with a drug candidate that targets the same protein.

Shmouni and Koehl Robinson unpack peptide medicine, from GLP-1s and BPC-157 to evidence, safety, regulation and personalized ...

Cala Health’s kIQ Plus now offers three stimulation modes and a calibration before each use, and it’s available across the US ...

Buck Institute’s Eric Verdin joins clinic leaders to tackle the ‘luxury diagnostic’ trap and the push for standardized care.